Granahan Investment Management Inc decreased Cardiovascular Systems (CSII) stake by 12.78% reported in 2017Q4 SEC filing. Granahan Investment Management Inc sold 39,100 shares as Cardiovascular Systems (CSII)’s stock declined 5.48%. The Granahan Investment Management Inc holds 266,958 shares with $6.32 million value, down from 306,058 last quarter. Cardiovascular Systems now has $759.70M valuation. The stock increased 0.79% or $0.18 during the last trading session, reaching $22.87. About 22,403 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has declined 21.67% since April 17, 2017 and is downtrending. It has underperformed by 33.22% the S&P500.
Evercore Wealth Management Llc decreased Nike Inc (NKE) stake by 2.27% reported in 2017Q4 SEC filing. Evercore Wealth Management Llc sold 12,579 shares as Nike Inc (NKE)’s stock rose 4.55%. The Evercore Wealth Management Llc holds 542,280 shares with $33.92M value, down from 554,859 last quarter. Nike Inc now has $108.75 billion valuation. The stock increased 0.62% or $0.416 during the last trading session, reaching $67.476. About 1.30 million shares traded. NIKE, Inc. (NYSE:NKE) has risen 18.31% since April 17, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.
Since December 11, 2017, it had 0 insider purchases, and 8 insider sales for $45.81 million activity. $620,000 worth of NIKE, Inc. (NYSE:NKE) was sold by Matheson Monique S.. $9.45M worth of NIKE, Inc. (NYSE:NKE) shares were sold by PARKER MARK G. Slusher John F also sold $4.75M worth of NIKE, Inc. (NYSE:NKE) on Friday, January 5. On Wednesday, January 31 the insider EDWARDS TREVOR A sold $6.85 million. $6.77M worth of stock was sold by SPRUNK ERIC D on Monday, January 29.
Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.06, from 0.8 in 2017Q3. It turned negative, as 70 investors sold NKE shares while 501 reduced holdings. 109 funds opened positions while 312 raised stakes. 1.01 billion shares or 2.95% more from 985.62 million shares in 2017Q3 were reported. Middleton & Inc Ma accumulated 32,940 shares. Minnesota-based Meristem Limited Liability Partnership has invested 0.38% in NIKE, Inc. (NYSE:NKE). Goldman Sachs invested in 12.02 million shares or 0.18% of the stock. Northeast Management has 1.29% invested in NIKE, Inc. (NYSE:NKE) for 246,188 shares. 178,275 are held by Kcm Invest Advsrs Limited. Acropolis Limited Liability Company owns 0.17% invested in NIKE, Inc. (NYSE:NKE) for 17,230 shares. Signaturefd Ltd Liability Co has invested 0.07% in NIKE, Inc. (NYSE:NKE). 35,328 were reported by Ibm Retirement Fund. Missouri-based Bkd Wealth Advsr Ltd Llc has invested 0.03% in NIKE, Inc. (NYSE:NKE). Olstein Cap Mngmt Lp has 61,000 shares. Westpac Bk has 0.12% invested in NIKE, Inc. (NYSE:NKE) for 85,629 shares. Logan Cap Mgmt owns 125,031 shares or 0.55% of their US portfolio. The New York-based Clearbridge Invs has invested 0.01% in NIKE, Inc. (NYSE:NKE). Ckw Financial Group Inc invested in 0.03% or 2,400 shares. Mu Invs accumulated 85,500 shares.
Analysts await NIKE, Inc. (NYSE:NKE) to report earnings on July, 5. They expect $0.64 EPS, up 6.67% or $0.04 from last year’s $0.6 per share. NKE’s profit will be $1.03 billion for 26.36 P/E if the $0.64 EPS becomes a reality. After $0.68 actual EPS reported by NIKE, Inc. for the previous quarter, Wall Street now forecasts -5.88% negative EPS growth.
Among 44 analysts covering Nike Inc. (NYSE:NKE), 25 have Buy rating, 2 Sell and 17 Hold. Therefore 57% are positive. Nike Inc. had 232 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Argus Research on Tuesday, April 4 to “Hold”. Morgan Stanley upgraded the stock to “Overweight” rating in Thursday, July 20 report. The company was maintained on Sunday, January 7 by Canaccord Genuity. Wells Fargo maintained the stock with “Market Perform” rating in Wednesday, September 28 report. Buckingham Research maintained the shares of NKE in report on Monday, December 18 with “Buy” rating. The stock has “Market Perform” rating by Wells Fargo on Wednesday, September 27. The stock of NIKE, Inc. (NYSE:NKE) has “Buy” rating given on Wednesday, September 28 by Citigroup. The rating was initiated by Guggenheim with “Buy” on Friday, September 30. The stock of NIKE, Inc. (NYSE:NKE) has “Buy” rating given on Tuesday, December 19 by Citigroup. On Wednesday, September 28 the stock rating was maintained by Robert W. Baird with “Outperform”.
Analysts await Cardiovascular Systems, Inc. (NASDAQ:CSII) to report earnings on May, 2 after the close. They expect $-0.02 EPS, down 166.67% or $0.05 from last year’s $0.03 per share. After $-0.01 actual EPS reported by Cardiovascular Systems, Inc. for the previous quarter, Wall Street now forecasts 100.00% negative EPS growth.
Granahan Investment Management Inc increased Bio Rad Labs (NYSE:BIO) stake by 18,000 shares to 50,350 valued at $12.02 million in 2017Q4. It also upped Sodastream International (NASDAQ:SODA) stake by 22,554 shares and now owns 439,709 shares. Wns Holdings Ltd (NYSE:WNS) was raised too.
Among 9 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Cardiovascular Systems had 25 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by Needham on Wednesday, June 29. The firm earned “Buy” rating on Thursday, October 8 by Dougherty & Company. On Thursday, January 26 the stock rating was maintained by Needham with “Buy”. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) has “Buy” rating given on Thursday, November 5 by Needham. Needham maintained the stock with “Strong Buy” rating in Thursday, August 6 report. The rating was maintained by Needham with “Buy” on Wednesday, August 30. The rating was upgraded by Leerink Swann on Monday, August 22 to “Outperform”. The rating was upgraded by Zacks on Friday, August 21 to “Sell”. The firm earned “Hold” rating on Friday, December 15 by Needham. The company was downgraded on Friday, January 22 by Needham.